TSHA TAYSHA GENE THERAPIES
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Thu 12 Nov 2026 · before market open
What 19 analyst firms say about TAYSHA GENE THERAPIES: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
19 rated views · 21 analyst/firm records · 19 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 3 reports on TSHA from 3 analyst firms in the last 90 days (20 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Cantor Fitzgerald raised its target from $13.00 (set 14 Nov 2025) to $19.00 on 12 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Jack Allen | Buy | 30 Jun 2026 | 15.00 USD |
| Bank of America Securities | Tazeen Ahmad | Buy | 22 Jun 2026 | 10.00 USD |
| BMO Capital Markets | Evan Seigerman | Buy | 23 Jun 2026 | 14.00 USD |
| BMO Capital Markets | Keith Tapper | Buy | 23 Jun 2026 | 14.00 USD |
| Canaccord Genuity | Whitney Ijem | Buy | 6 Apr 2026 | 17.00 USD |
| Cantor Fitzgerald | Kristen Kluska | Buy | 12 Aug 2026 | 19.00 USD |
| Chardan Capital Markets | Geulah Livshits | Buy | 19 Mar 2026 | 12.00 USD |
| Citigroup | Unnamed analyst | Buy | 23 Jun 2026 | — |
| Citizens JMP | Silvan C Tuerkcan | Buy | 23 Jun 2026 | 11.00 USD |
| Citizens JMP | Silvan Turkcan | Buy | 2 Jul 2026 | 11.00 USD |
| Goldman Sachs | Salveen Richter | Buy | 21 Jul 2026 | 13.00 USD |
| Jefferies | Maury Raycroft | Buy | 23 Jun 2026 | 14.00 USD |
| Needham | Gil Blum | Buy | 30 Jun 2026 | 12.00 USD |
| Piper Sandler | Biren Amin | Buy | 22 Jun 2026 | — |
| Raymond James | Christopher Raymond | Buy | 29 Jun 2026 | 13.00 USD · 6 Jan 2026 |
| Truist | Unnamed analyst | Buy | 25 Mar 2026 | — |
| UBS | Unnamed analyst | — | 4 Dec 2025 | 11.00 USD |
| Weiss Ratings | Unnamed analyst | — | 21 Sep 2026 | — |
| Wells Fargo | Yanan Zhu | Buy | 7 May 2026 | 11.00 USD |
| Wolfe Research | Kalpit Patel | Buy | 17 Sep 2026 | 9.00 USD |
| Data feed RESEARCH | Research Team | Hold | 3 Apr 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:01 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.